UQ Centre for Clinical Research, The University of Queensland, Herston, QLD 4029, Australia.
Drug Alcohol Rev. 2012 Mar;31(2):194-7. doi: 10.1111/j.1465-3362.2011.00345.x. Epub 2011 Sep 29.
The majority view among alcohol epidemiologists is that the lower coronary heart disease mortality observed in moderate drinkers is probably evidence for a protective effect of moderate drinking. In this paper I critically discuss the debate about what type of information, if any, should be provided to the public about the putative coronary heart disease benefits of moderate alcohol use.
Most opposition to informing the public about these putative benefits is based on the fear that such advice will increase per capita alcohol consumption and therefore alcohol-related harm. It is unclear how well-based these concerns are. In the interim, the alcohol industry has communicated these putative benefits to the public.
There is a case for including some information on these putative benefits in specific safer drinking guidelines for middle-aged and older drinkers that: clearly conveys the remaining uncertainty about the benefits of moderate drinking, emphasises the conditional nature of any such benefits, and stresses the need to balance the potential benefits against the increased sensitivity of older adults to other adverse effects of alcohol, and the increased risk of interactions between alcohol and other medications used by older adults.
大多数酒精流行病学专家认为，观察到适量饮酒者的冠心病死亡率较低，这可能是适量饮酒具有保护作用的证据。在本文中，我将批判性地讨论关于应向公众提供何种信息（如果有）的争议，这些信息涉及适量饮酒对冠心病可能的益处。
大多数人反对向公众提供这些潜在益处的信息，主要是担心这种建议会增加人均酒精摄入量，从而增加与酒精相关的伤害。目前尚不清楚这些担忧的依据有多充分。在此期间，酒精行业已经向公众传达了这些潜在的益处。
有理由在针对中年和老年饮酒者的特定安全饮酒指南中纳入一些关于这些潜在益处的信息：明确传达关于适量饮酒益处的剩余不确定性，强调任何此类益处的条件性，并强调需要权衡潜在益处与老年人对酒精其他不良反应的敏感性增加以及老年人饮酒与其他药物相互作用的风险增加之间的平衡。
